Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
948.3 INR | -0.88% |
|
+0.70% | +46.06% |
May. 23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
May. 22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.06% | 1.05B | |
+16.80% | 43.26B | |
+17.47% | 21.6B | |
+21.21% | 15.93B | |
+23.95% | 15.1B | |
+57.96% | 12.95B | |
-0.05% | 6.79B | |
-16.22% | 6.29B | |
+19.77% | 6.04B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Transcript : Strides Pharma Science Limited, Q3 2022 Earnings Call, Feb 10, 2022